Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | The evolving field of antithrombotic therapy in secondary stroke prevention

Marc Fisher, MD, Beth Israel Deaconess Medical Center, Boston, MA, discusses the current state of antithrombotic strategies for secondary prevention after stroke or transient ischemic attack (TIA). Prof. Fisher then discusses how factor XIa inhibitors may change this approach. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.